Glickman Marc H. 4
4 · Hancock Jaffe Laboratories, Inc. · Filed Feb 22, 2021
Insider Transaction Report
Form 4
Glickman Marc H.
See Remarks
Transactions
- Award
Stock Option
2021-02-18+406,000→ 406,000 totalExercise: $8.20Exp: 2031-02-18→ Common Stock (406,000 underlying)
Footnotes (2)
- [F1]The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan").
- [F2]The stock options vest in equal quarterly installments over a two a year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void.